Mereo BioPharma Group plc
Acquires and develops clinical-stage therapies for rare diseases.
MREO | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- ONE CAVENDISH PLACE, LONDON
- Website:
- https://www.mereobiopharma.com/
- Sector:
- Manufacturing
Description
Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases with limited or no treatment options. The company's strategy involves acquiring and advancing promising clinical-stage product candidates that have been de-prioritized by larger pharmaceutical or biotechnology companies. This capital-efficient model allows it to develop a specialized pipeline. Its two lead programs are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for Alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). Mereo BioPharma also engages in strategic partnerships and out-licenses other clinical assets to deliver impactful treatments to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2018-10-01 12:00 |
Revised Credit Facility and Issue of Warrants
|
English | HTML • 23.3 KB | ||
| 2018-09-03 09:00 |
Block Listing Application
|
English | HTML • 19.2 KB | ||
| 2018-08-31 20:25 |
Correction to Issued Share Capital
|
English | HTML • 19.3 KB | ||
| 2018-06-21 14:52 |
Result of Annual General Meeting
|
English | HTML • 18.7 KB | ||
| 2018-05-29 09:00 |
Successful Completion of PrimaryBid Offer
|
English | HTML • 18.2 KB | ||
| 2018-05-25 18:31 |
PrimaryBid.com Offer
|
English | HTML • 26.9 KB | ||
| 2018-05-22 09:00 |
Notice of AGM
|
English | HTML • 16.1 KB | ||
| 2018-04-27 09:00 |
Grant of Options
|
English | HTML • 33.0 KB | ||
| 2018-04-26 09:00 |
Update on Offering & Application to List on Nasdaq
|
English | HTML • 22.2 KB | ||
| 2018-04-09 13:34 |
Offering and Application to List on Nasdaq
|
English | HTML • 26.2 KB | ||
| 2018-04-06 15:03 |
Result of General Meeting
|
English | HTML • 16.6 KB | ||
| 2018-03-26 09:00 |
Mereo BioPharma Files for Proposed Global Offering
|
English | HTML • 22.9 KB | ||
| 2018-03-23 08:00 |
Final Results
|
English | HTML • 293.1 KB | ||
| 2018-03-20 08:00 |
PUBLICATION OF NOTICE OF GENERAL MEETING
|
English | HTML • 11.7 KB | ||
| 2018-03-20 08:00 |
Mereo selected for oral presentation at ATS 2018
|
English | HTML • 24.0 KB |
Automate Your Workflow. Get a real-time feed of all Mereo BioPharma Group plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mereo BioPharma Group plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mereo BioPharma Group plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
